- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.08. | McKesson strikes $2.25B deal to snap up Precision Medicine Group | ||
| 25.08. | Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3 | ||
| 25.08. | Johnson & Johnson scores 1st FDA label expansion for Imaavy | ||
| 24.08. | Merck, AstraZeneca lawsuits against Medicare price negotiations swatted down | ||
| 24.08. | Hansa lays groundwork for Nasdaq debut ahead of US kidney transplant drug verdict | ||
| 24.08. | After Trump order, RFK Jr. seeks input on US pediatric vaccine recommendations | ||
| 24.08. | Cellares CEO seeks to 'resize' company after loss of 'large' cell therapy manufacturing customer | ||
| 24.08. | Daiichi Sankyo promotes Ken Keller to lead new commercialization unit | ||
| 21.08. | Lundbeck continues neuroscience evolution as CEO keeps company 'punching above its weight' | ||
| 21.08. | The Oral GLP-1 Tracker: Novo's Wegovy pill back on track as Lilly's momentum slows | ||
| 20.08. | Roche earmarks $750M to double the size of its Oregon manufacturing facility | ||
| 20.08. | Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns | ||
| 20.08. | Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036 | ||
| 20.08. | B. Braun recalls IV solution from US, Canada hospitals on particle contamination concerns | ||
| 20.08. | Lucid Group names leading Publicis Health exec as new CEO | ||
| 20.08. | Boehringer Ingelheim again rises up rare disease reputation rankings | ||
| 19.08. | SK strikes settlement with MSN over future Xcopri generic: reports | ||
| 19.08. | Contractor SK Pharmteco heralds completion of 2 API plants in Ireland | ||
| 19.08. | Aurobindo unit, China API maker dinged in latest round of FDA warning letters | ||
| 19.08. | Genetix kicks off sickle cell disease awareness campaign with NFL Alumni Association | ||
| 18.08. | Revance hires Janelle Wichmann as chief marketing officer of skincare unit | ||
| 18.08. | Pharma commercialization partner Valeris brings in new strategy chief | ||
| 18.08. | CSL shares up 17% as immunoglobulin boost points to signs of recovery | ||
| 18.08. | Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS' global test | ||
| 18.08. | CMI adopts orphan drug field with dedicated center of excellence |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.